400-82-0725
50.44
[]. Wempe MF, et, al. Developing potent human uric acid transporter (hURAT) inhibitors. J Med Chem. 20 Apr 28;54(8):270-.
[2]. A M Ehrly, et al. [Behavior of muscle tissue oxygen pressure in patients with severe intermittent claudication after oral administration of benzarone]. Med Welt. 98 Mar 4;4(9):27-4.
[]. Emmanuel Tadjuidje, et al. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone. PLoS One. 202;7(4):e4806.
[4]. H E Knehr, et al. [Effect of benzarone on the oxygen consumption and the mechanical activity of vascular smooth muscle]. Arzneimittelforschung. 98;(2):2-4.
[5]. Ho Jung Shin, et al. Interactions of urate transporter URAT in human kidney with uricosuric drugs. Nephrology (Carlton). 20 Feb;6(2):56-62.
H02-H4
P264-P270-P27-P0
05766 现货
￥ ļėƓƀææ -00mg
29955 货期咨询
04576 货期咨询
￥ Ŋæǐƀææ -g
0049 货期咨询
￥ ǐIJƓƀææ -25mg
45044 货期咨询
6744 货期咨询
￥ ėƋæƀææ -g
45046 货期咨询
￥ ŊėėƸƀææ -0mg
8462 货期咨询
￥ ǐæææƀææ -5mg
6248 货期咨询
￥ IJŊŊƀææ -g
2486 货期咨询
沪ICP备709645号
